REGULATORY INTELLIGENCE·Recall
FDA Class II Recall: Asteria Health's Testosterone Pellets Contaminated with Metal Particulate
F.H. INVESTMENTS, Inc. (dba Asteria Health) has initiated a Class II recall of 194,336 Testosterone, 200 mg sterile pellets due to potential metal particulate contamination. This event highlights critical quality control challenges in sterile drug manufacturing, necessitating immediate action from procurement and regulatory teams to assess supply chain exposure and identify alternative suppliers for this essential hormone therapy.
90-Day Activity
F.H. INVESTMENTS,Esokalli Testosterone Booster Oral Dissolving FilmHSN 3004.39
CMCatherine Morrow· Senior Regulatory Intelligence Analyst2026-02-18